Study of cutaneous T-cell lymphoma at Hospital México, Costa Rica
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at how cutaneous T-cell lymphoma (a rare type of skin lymphoma) is diagnosed and treated at a specific hospital in Costa Rica. It aims to understand the disease better and improve care for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of cutaneous T-cell lymphoma.
- You must be 18 years or older.
- You must have had at least one dermatology visit during the study period (2019–2025).
- You must have received treatment for the condition, such as light therapy, creams, radiation, or systemic therapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study creates a registry for people with certain T-cell or NK-cell lymphomas. It collects health information and tumor samples to learn more about these diseases and improve future treatments.
This study collects blood and tumor tissue samples from people newly diagnosed with aggressive non-Hodgkin lymphoma who will receive standard chemotherapy. The goal is to improve future tests for detecting minimal residual disease (tiny amounts of cancer left after treatment).
This study looks at people with Hansen's disease (leprosy) in Costa Rica to understand how it affects them and how it's treated. By joining, you help researchers learn more about this condition to improve care for others.
This study looks at how psoriasis affects children in Costa Rica, including what treatments they receive. It helps doctors understand the condition better and improve care for kids with psoriasis.
This study looks at skin lymphomas (a type of white blood cell cancer that starts in the skin) to find factors that predict how the disease will progress and to identify new ways to treat it. By joining, you help researchers understand and improve treatment for this condition.
This study follows people with primary cutaneous T-cell lymphoma who are seen at the Dermatology Unit in Pavia. It collects information to better understand the disease and improve care.
Hear when a new T-cell Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.